You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 7, July 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  CORRESPONDENCE
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Increased Prevalence of HIV-Related Retinal Microangiopathy Syndrome in Patients With Hepatitis C

Soeren Thierfelder, MD; Doris Linnert, MD; Franz Grehn, MD
Wuerzburg, Germany

Arch Ophthalmol. 1996;114(7):899.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Despite several suggested theories, the pathogenesis of human immunodeficiency virus (HIV)-related retinal microangiopathy syndrome (MAPS), consisting of cotton-wool spots and retinal hemorrhages, is not yet understood. A direct endothelial cell infection,1 an immunocomplex vasculitis,2 and an increased serum concentration of endotheline3 have been considered as its possible origins.

Since January 1992 we have examined 125 patients with HIV infection using the Centers for Disease Control and Prevention (CDC) classification of HIV type 1 (HIV-1) infection (CDC 1 classified patients, 1; CDC 2, 47; CDC 3, 7; CDC 4, 70 [Table 1 ]). Fifty of these patients also tested positive for infection with hepatitis C virus (HCV) (CDC 1, 0 patients; CDC 2, 16; CDC 3, 4; CDC 4, 30). This high prevalence of infection with both HIV and HCV can be explained by an overproportional rate of injecting drug users. None of our patients had been subjected to . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.